Journal article
Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies
PET clinics, v 14(3), pp 331-340
01 Jul 2019
PMID: 31084773
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
The role of F-18-fluorodeoxyglucose PET/computed tomography in hematological malignancies continues to expand in disease diagnosis, staging, and management. A key advantage of PET over other imaging modalities is its ability to quantify tracer uptake, which can be used to determine degree of disease activity. Although tracer uptake with PET is conventionally measured in focal lesions, novel quantitative techniques are being investigated that set objective protocols and produce robust parameters that represent total disease activity portrayed by PET. This article discusses recent advances in PET quantification that can improve reliability and accuracy of characterizing hematological malignancies.
Metrics
Details
- Title
- Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies
- Creators
- William Y. Raynor - Drexel UniversityMahdi Zirakchian Zadeh - Children's Hospital of PhiladelphiaEsha Kothekar - University of PennsylvaniaDani P. Yellanki - University of PennsylvaniaAbass Alavi - University of Pennsylvania
- Publication Details
- PET clinics, v 14(3), pp 331-340
- Publisher
- Elsevier
- Number of pages
- 11
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiology (Radiologic Sciences)
- Web of Science ID
- WOS:000467624300004
- Scopus ID
- 2-s2.0-85063972044
- Other Identifier
- 991019350668304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Radiology, Nuclear Medicine & Medical Imaging